Live data from Hacker News

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

biorxiv.org

21–30 of 131 posts

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#21
post #15

A new mutation of COVID19 has been discovered in an South African donor. With this mutation, the spike protein changed which might render all existing vaccinations less effective or even ineffective.

Do you have a link, or some sort of corroborating evidence to support this statement

That was in the article.

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#22
post #5

Pulling directly from TFA, > Here we show that this lineage exhibits complete escape from three classes of therapeutically relevant monoclonal antibodies. Furthermore 501Y.V2 shows substantial or complete escape from neutralizing antibodies in COVID-19 convalescent plasma. These data highlight the prospect of reinfection with antigenically distinct variants and may foreshadow reduced efficacy of current spike-based v…

> The callouts there are "complete escape [from] convalescent plasma" (prior exposure won't help you)

Whether prior exposure helps also depends on T-cell response. At this point it's well established that immunity lasts for some unknown period of time past when most antibodies have left the bloodstream.

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#23
1. Abstract:

"SARS-CoV-2 501Y.V2, a novel lineage of the coronavirus causing COVID-19, contains multiple mutations within two immunodominant domains of the spike protein. Here we show that this lineage exhibits complete escape from three classes of therapeutically relevant monoclonal antibodies. Furthermore 501Y.V2 shows substantial or complete escape from neutralizing antibodies in COVID-19 convalescent plasma. These data highlight the prospect of reinfection with antigenically distinct variants and may foreshadow reduced efficacy of current spike-based vaccines."

2. See also:

* "New coronavirus variants could cause more re-infections, require vaccine updates": https://www.sciencemag.org/news/2021/01/new-coronavirus-vari...

* "Can we stop a super coronavirus?": https://www.spiegel.de/international/world/can-germany-stop-...

* Tweets by an epidemiologist at Harvard about the new variants found in Manaus, Brazil: https://twitter.com/BillHanage/status/1349943613514526723

3. A key takeaway, for me:

Evolutionary paths for covid-19 that would normally be very unlikely become more and more likely as more people get infected with the virus, providing a large-scale, global playground for experimentation via random mutation. Random evolutionary events that would normally be rare become more and more likely as the numbers grow large enough.

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#24
post #5

Pulling directly from TFA, > Here we show that this lineage exhibits complete escape from three classes of therapeutically relevant monoclonal antibodies. Furthermore 501Y.V2 shows substantial or complete escape from neutralizing antibodies in COVID-19 convalescent plasma. These data highlight the prospect of reinfection with antigenically distinct variants and may foreshadow reduced efficacy of current spike-based v…

exiting discussion

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#25
the government of my region has decide that instead of following normal vaccination procedures, they will spread the available vaccine (Pfizer) to just give 1 dose to as many people as possible as opposed to the 2 required to be effective as per the clinical trials and the manufacturers advice. This decision is purely political, defying all biological evidence.

Seems to me this is the perfect scenario to evolve vaccine resistant variants.

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#26
post #10

Note that 1. The sera they tested this against obtained antibodies through natural infection. It's not clear whether vaccine-induced immunity is protective against this variant. 2. They only tested for neutralizing antibodies, but there is still T-Cell response which could provide protection.

The primary benefit of the vaccine over 'natural' immunity (other than avoiding actual exposure) is the emphasis on neutralizing antibody formation.

I had assumed the vaccine was also intended/believed to induce T-cell response, is that not the case? Given that they disappear within a matter of months after a natural infection, how long are the antibodies from the vaccines believed to last?

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#27
I for one am not concerned. The true mortality rate appears to be 65. What does that mean?

To put it into perspective you may only know one person in your friend group which knows one person who dies.

Your friends / family are more likely to die of cancer.

How often do you know someone die of cancer?

It's definitely unfortunate; we should all socially distance & wear N95's where possible. All of us can decide if we want to stay locked down or not. Probably half the population will, so the spread will be much lower than otherwise. The rest of the population can keep working, making money and feeding their children.

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#29
post #20

Earlier quoted context omitted.

It would seem that the horse is already out of the barn. Flights would have needed to be curtailed much earlier. In addition, we're seeing similar mutations popping up independently in geographical areas - seems to be evolutionary pressure in these directions.

Understood, but if we can contain the mutations regionally, it’s better than having them spread globally.

The rise of these variants shows that we have to do a much better job with genomic analysis and surveillance and we have to be willing to be more proactive about shutting down travel to/from regions where these variants show up. I'm just not sure we have the political will to do what the science would suggest - we didn't for the original covid-19 and as it spread around the world political leaders of all stripes were slow to listen to the scientists. I guess I'm not sure that's going to change.

Re: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

#30
post #20

Earlier quoted context omitted.

It would seem that the horse is already out of the barn. Flights would have needed to be curtailed much earlier. In addition, we're seeing similar mutations popping up independently in geographical areas - seems to be evolutionary pressure in these directions.

Understood, but if we can contain the mutations regionally, it’s better than having them spread globally.

I think you lost me. How can we have an unfettered economy, not limited by lockdowns AND contain mutations regionally? These two statements you have made seem to be at odds with one another. Or am I overthinking/underthinking this?
Post reply on HN